Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
Saved in:
| Published in: | Lung Cancer: Targets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552400235659264 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Lung Cancer: Targets and Therapy |
| description | |
| discipline_display | Respiratory Diseases |
| discipline_facet | Respiratory Diseases |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:58413 |
| institution | FRELIP |
| journal_source_facet | Lung Cancer: Targets and Therapy |
| last_indexed | 2026-06-20T21:19:56.163Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China Respiratory Diseases General Respiratory Diseases |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Respiratory Diseases General Respiratory Diseases |
| subject_facet | Respiratory Diseases General Respiratory Diseases |
| title | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_alt | Estudio observacional prospectivo del mundo real de afatinib como tratamiento de primera línea en pacientes chinos con cáncer de pulmón de células no pequeñas avanzado con mutación del receptor del factor de crecimiento epidérmico (EGFR) positivo Étude observationnelle prospective en conditions réelles de l'afatinib en traitement de première ligne chez des patients chinois atteints de cancer du poumon non à petites cellules avancé avec mutation du récepteur du facteur de croissance épidermique (EGFR) Estudo Prospectivo Observacional de Mundo Real de Afatinibe como Tratamento de Primeira Linha em Pacientes com Câncer de Pulmão de Células Não Pequenas (CPNPC) Avançado com Mutação do Receptor do Fator de Crescimento Epidérmico (EGFR) na China |
| title_auth | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_es_txt | Estudio observacional prospectivo del mundo real de afatinib como tratamiento de primera línea en pacientes chinos con cáncer de pulmón de células no pequeñas avanzado con mutación del receptor del factor de crecimiento epidérmico (EGFR) positivo |
| title_fr_txt | Étude observationnelle prospective en conditions réelles de l'afatinib en traitement de première ligne chez des patients chinois atteints de cancer du poumon non à petites cellules avancé avec mutation du récepteur du facteur de croissance épidermique (EGFR) |
| title_full | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_fullStr | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_full_unstemmed | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_pt_txt | Estudo Prospectivo Observacional de Mundo Real de Afatinibe como Tratamento de Primeira Linha em Pacientes com Câncer de Pulmão de Células Não Pequenas (CPNPC) Avançado com Mutação do Receptor do Fator de Crescimento Epidérmico (EGFR) na China |
| title_short | Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China |
| title_sort | prospective observational real-world study of afatinib as first-line treatment in patients with epidermal growth factor receptor (egfr) mutation-positive advanced non-small cell lung cancer (nsclc) in china |
| topic | Respiratory Diseases General Respiratory Diseases |
| url | https://www.dovepress.com/prospective-observational-real-world-study-of-afatinib-as-first-line-t-peer-reviewed-fulltext-article-LCTT |